Stocktoria

Acurx Pharmaceuticals, Inc. ACXP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-25 · LEI

Acurx Pharmaceuticals, Inc. statistics & valuation

Market cap$6.5M
P / B1.2×
Return on equity-151.2%
Return on capital-153.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-170.30% -102.70% -165.30% -312.40% -2292.70% -151.20% 202020212022202320242025
Shares outstanding
6.2M 10.2M 11.6M 14.5M 851534 2.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-142.70% -96.20% -129.00% -189.10% -365.60% -103.60% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.74 -$1.49 -$1.12 -$1.15 -$17.45 -$5.32 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-103.6%-365.6%-189.1%-129.0%-96.2%-142.7%
Return on equity-151.2%-2292.7%-312.4%-165.3%-102.7%-170.3%
Current ratio—1.192.534.5515.71—

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.